The market is further supported by the expansion of home-based and point-of-care testing services, in conjunction with advancements in technology, including smartphone integration, wearable device compatibility, and AI-driven data tracking. Currently, North America holds the largest share of the market, attributed to its advanced healthcare infrastructure and high levels of diabetes awareness.